Skip to main navigation Skip to search Skip to main content

Oral sustained delivery of ambroxol from in situ-gelling pectin formulations

  • Wataru Kubo
  • , Shozo Miyazaki
  • , Masatake Dairaku
  • , Mitsuo Togashi
  • , Ryozo Mikami
  • , David Attwood

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Gels formed in situ following oral administration of dilute aqueous solutions of pectin (1.0 and 1.5%, w/v) to rats were evaluated as vehicles for the sustained release of the expectorant drug ambroxol hydrochloride. The solutions contained calcium ions in complexed form, which on release in the acidic environment of the stomach caused gelation of the pectin. In vitro studies demonstrated diffusion-controlled release of ambroxol from the gels over a period of 6h. A bioavailability of ambroxol of approximately 64% of that of a commercially available formulation could be achieved from gels containing an identical dose of ambroxol formed in situ in the stomachs of rats, with appreciably lower peak plasma levels and a sustained release of drug over a period of at least 6h. The influence of added sorbitol (17%, w/v) on the rheological and drug release properties of the formulations has been examined. © 2004 Elsevier B.V. All rights reserved.
    Original languageEnglish
    Pages (from-to)233-240
    Number of pages7
    JournalInternational Journal of Pharmaceutics
    Volume271
    Issue number1-2
    DOIs
    Publication statusPublished - 1 Mar 2004

    Keywords

    • Ambroxol
    • In situ gelation
    • Oral drug delivery
    • Pectin gels
    • Sustained release

    Fingerprint

    Dive into the research topics of 'Oral sustained delivery of ambroxol from in situ-gelling pectin formulations'. Together they form a unique fingerprint.

    Cite this